Validation of a Novel Commercial ELISA Test for the Detection of Antibodies against Coxiella burnetii
Open Access
Abstract
Q fever is a zoonosis caused by Coxiella burnetii, a Gram-negative pathogen with a complex life cycle and a high impact on public and animal health all over the world. The symptoms are indistinguishable from those belonging to other diseases, and the disease could be symptomless. For these reasons, reliable laboratory tests are essential for an accurate diagnosis. The aim of this study was to validate a novel enzyme-linked immunosorbent assay (ELISA) test, named the Chorus Q Fever Phase II IgG and IgM Kit (DIESSE, Diagnostica Senese S.p.A), which is performed by an instrument named Chorus, a new device in medical diagnostics. This diagnostic test is employed for the detection of antibodies against C. burnetii Phase II antigens in acute disease. Our validation protocol was performed according to the Italian Accreditation Body (ACCREDIA) (Regulation UNI CEI EN ISO/IEC 17025:2018 and 17043:2010), OIE (World Organization for Animal Health), and Statement for Reporting Studies of Diagnostic Accuracy (STARD). Operator performance was evaluated along with the analytical specificity and sensitivity (ASp and ASe) and diagnostic accuracy of the kit, with parameters such as diagnostic specificity and sensitivity (DSp and DSe) and positive and negative predictive values (PPV and NPV), in addition to the repeatability. According to the evaluated parameters, the diagnostic ELISA test was shown to be suitable for validation and commercialization as a screening method in human sera and a valid support for clinical diagnostics.Keywords
This publication has 49 references indexed in Scilit:
- High Seroprevalence of Mycoplasma pneumoniae IgM in Acute Q Fever by Enzyme-Linked Immunosorbent Assay (ELISA)PLOS ONE, 2013
- Potential serodiagnostic markers for Q fever identified in Coxiella burnetiiby immunoproteomic and protein microarray approachesBMC Microbiology, 2012
- Comparison of ELISA and indirect immunofluorescent antibody assay detecting Coxiella burnetii IgM phase II for the diagnosis of acute Q feverEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Isolation from Animal Tissue and Genetic Transformation of Coxiella burnetii Are Facilitated by an Improved Axenic Growth MediumApplied and Environmental Microbiology, 2011
- Long-term outcome of Q fever endocarditis: a 26-year personal surveyThe Lancet Infectious Diseases, 2010
- Real-Time PCR with Serum Samples Is Indispensable for Early Diagnosis of Acute Q FeverClinical and Vaccine Immunology, 2010
- Diagnostic methods I: sensitivity, specificity, and other measures of accuracyKidney International, 2009
- Candidate Antigens for Q Fever Serodiagnosis Revealed by Immunoscreening of a Coxiella burnetii Protein MicroarrayClinical and Vaccine Immunology, 2008
- Identification of protein candidates for the serodiagnosis of Q fever endocarditis by an immunoproteomic approachEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD InitiativeClinical Chemistry, 2003